Canada· CA-DIN-02473720

SYMTUZA

A emtricitabine, tenofovir alafenamide, darunavir and cobicistat product containing emtricitabine + tenofovir alafenamide (tenofovir alafenamide hemifumarate) + darunavir (darunavir ethanolate) + cobicistat, registered in Canada by JANSSEN INC. The same ATC class is registered in 12 of our 19 countries.

ATC J05AR22

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedSYMTUZAATCJ05AR22REGISTER NO.CA-DIN-02473720PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat is registered in 12 of 19 countries.

Countries holding a registration under ATC J05AR22 (emtricitabine, tenofovir alafenamide, darunavir and cobicistat), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat · ATC J05AR22

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
EMTRICITABINE + TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) + DARUNAVIR (DARUNAVIR ETHANOLATE) + COBICISTAT
Manufacturer
JANSSEN INC
Country
Canada (CA)
ATC code
J05AR22
ATC class
Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide, darunavir and cobicistat in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide, darunavir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Symtuza
  • Liechtenstein · Symtuza
  • Norway · Symtuza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7401e642-86f6-435e-b299-8183bd30a874
GET /v1/drugs/7401e642-86f6-435e-b299-8183bd30a874?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02473720",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "J05AR22",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "96312",
  "strengths": [
    "200 MG",
    "10 MG",
    "800 MG",
    "150 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "EMTRICITABINE",
    "TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE)",
    "DARUNAVIR (DARUNAVIR ETHANOLATE)",
    "COBICISTAT"
  ],
  "product_categorization": null
}

See everything about emtricitabine, tenofovir alafenamide, darunavir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.